Alexander Brown, MD
Rheumatology · Lexington, KYNPI 1043250343
Payments from drug & device makers
Across 509 payments — averaging $1206.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$270K
- Amgen$233K
- UCB SA$46K
- Novartis$33K
- UCB, Inc.$25K
- UCB Biosciences Inc.$2K
- plus $4K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 32 | $269,603 |
| Amgen(2 entities) | 112 | $233,304 |
| UCB SA | 4 | $46,220 |
| Novartis | 64 | $33,496 |
| UCB, Inc. | 25 | $24,924 |
| UCB Biosciences Inc. | 9 | $2,051 |
| AbbVie | 72 | $1,333 |
| Pfizer | 54 | $611 |
| Johnson & Johnson | 32 | $514 |
| Boehringer Ingelheim | 13 | $243 |
| GSK | 13 | $219 |
| E.r. Squibb & Sons, L.L.C. | 10 | $174 |
| Mallinckrodt Hospital Products Inc. | 5 | $165 |
| AstraZeneca(2 entities) | 8 | $148 |
| Regeneron Healthcare Solutions, Inc. | 9 | $136 |
| Lilly USA, LLC | 6 | $120 |
| Bristol Myers Squibb | 5 | $99 |
| Radius Health, Inc. | 5 | $76 |
| Genentech USA, Inc. | 5 | $74 |
| Aurinia Pharma U.S., Inc. | 4 | $67 |
| Sobi, Inc | 3 | $60 |
| Organon | 4 | $54 |
| Daiichi Sankyo Inc. | 2 | $35 |
| EMD Serono, Inc. | 2 | $35 |
| Fresenius Kabi USA, LLC | 2 | $34 |
| Skeletal Dynamics Inc | 1 | $33 |
| Sanofi | 1 | $29 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
| Antares Pharma, Inc. | 1 | $25 |
| Octapharma USA, Inc. | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Mylan Institutional Inc. | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Si-bone, Inc. | 1 | $17 |
How this compares
$614,000 in reported general payments places this provider in the 95th percentile of 81 rheumatology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Lexington
- Jeffrey NealLexington$1.8M
- Paramarajan PiranavanLexington$283K
- Kelly ColeLexington$9K
- Elaine AlexanderLexington$8K
- Lucia HardiLexington$7K
- Izabela AnticLexington$5K
- Corey HatfieldLexington$4K
- Syed Haider AbbasLexington$3K
- Amna BatoolLexington$2K
- Robert LightfootLexington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.